Better Sleep in Psychiatric Care - Depression, Anxiety and PTSD
BSIP-DAP
1 other identifier
interventional
130
1 country
1
Brief Summary
Cognitive Behavioral Therapy (CBT) is treatment of choice for insomnia. Many patients in psychiatric care have sleep problems including insomnia, but are rarely given the choice to participate in CBT to improve their sleep. Patients with PTSD, Anxiety disorders and Depression display high levels of sleep difficulties. Sleep problems are often general, such as insomnia and sleep phase problems. In a previous pilot study, the investigators of the current study developed a CBT protocol that would target sleep problems in this mixed psychiatric population. The basis was CBT for insomnia (CBT-i), but also including techniques that would alleviate sleep phase problems (e.g. the systematic use of light and darkness), and techniques to target more general sleep related problems (e.g. difficulties waking up in the morning), that are also common in psychiatric patients. This treatment was well tolerated and gave large withing-group effects on insomnia severity in the pilot study. In a naturalistic randomized controlled trial, the investigators now evaluate the effects of this psychological treatment on sleep and anxiety and depressive symptoms in patients at the units for Anxiety and Affective disorders and Trauma, Southwest Psychiatry and Northern Stockholm Psychiatry, Stockholm County Council, Sweden.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 25, 2019
CompletedFirst Submitted
Initial submission to the registry
October 21, 2019
CompletedFirst Posted
Study publicly available on registry
October 23, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedAugust 12, 2024
August 1, 2024
5.1 years
October 21, 2019
August 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Insomnia Severity Index (ISI)
7-item, self-rated questionnaire measuring insomnia severity. Total score 0-28, higher score indicates more severe sleep problems.
Changes from base-line to 8 weeks, 5 months and 14 months
Secondary Outcomes (6)
Actigraphy
Changes from base-line to post 8 weeks
WHO Disability Assessment Schedule (WHODAS)
Changes from base-line to 8 weeks, 5 months and 14 months
Patient Health Questionnaire (PHQ-9)
Changes from base-line to 8 weeks, 5 months and 14 months
Generalized Anxiety Disorder 7-item scale (GAD-7)
Changes from base-line to 8 weeks, 5 months and 14 months
Sleep habits and behaviors
Changes from base-line to 8 weeks, 5 months and 14 months
- +1 more secondary outcomes
Study Arms (2)
Adjusted group CBT-i for Depression, Anxiety and PTSD
EXPERIMENTALCognitive Behavioral group intervention for sleep problems in patients with Depression, Anxiety and PTSD, based on Cognitive Behavioral Therapy for insomnia
Care as usual wait-list control group
ACTIVE COMPARATORTreatment as Usual. (After about five months, participants in this condition are offered the experimental group treatment.)
Interventions
Adjusted group CBT-i for Depression, Anxiety and PTSD. CBT-i includes sleep scheduling/sleep compression, stimulus control, relaxation, cognitive interventions and sleep hygiene advice. Adjustments include the relationship between sleep and the psychiatric conditions at hand and and working with motivational enhancement techniques to increase adherence to treatment.
Usual care at the clinic. This entails managing pharmacological treatment for the psychiatric problems and/or sleep problems. The clinic also provides different group treatments, such as mindfulness groups and CBT groups for symptoms of worry and depression, and individual therapy.
Eligibility Criteria
You may qualify if:
- Being a patient at the clinics involved in the project
- Experiencing sleep problems (subjective report)
- Being able to participate in a psychological intervention in group format
You may not qualify if:
- Night shift work
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Region Stockholmcollaborator
Study Sites (1)
Program for Affective disorders, Anxiety and Trauma, Stockholm Southwest Psychiatry
Stockholm, 141 86, Sweden
Related Publications (1)
Cassel M, Blom K, Gatzacis J, Renblad P, Kaldo V, Jernelov S. Clinical feasibility of cognitive behavioural therapy for insomnia in a real-world mixed sample at a specialized psychiatric outpatient clinic. BMC Psychiatry. 2022 Sep 9;22(1):600. doi: 10.1186/s12888-022-04231-4.
PMID: 36085009BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susanna Jernelöv, PhD
Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 21, 2019
First Posted
October 23, 2019
Study Start
September 25, 2019
Primary Completion
November 1, 2024
Study Completion
June 1, 2025
Last Updated
August 12, 2024
Record last verified: 2024-08